Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Why prescribe exercise as therapy in type 2 diabetes? We have a pill for that!

Research output: Contribution to journalReviewResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{84d7f0a6b7eb498c834e3c0688e895c0,
title = "Why prescribe exercise as therapy in type 2 diabetes?: We have a pill for that!",
abstract = "The majority of T2D cases are preventable through a healthy lifestyle, leaving little room for questions that lifestyle should be the first line of defence in the fight against the development of T2D. However, when it comes to the clinical care of T2D, the potential efficacy of lifestyle is much less clear-cut, both in terms of impacting the pathological metabolic biomarkers of the disease, and long-term complications. A healthy diet, high leisure-time physical activity, and exercise are considered to be cornerstones albeit adjunct to drug therapy in the management of T2D. The prescription and effective implementation of structured exercise and other lifestyle interventions in the treatment of T2D have not been routinely used. In this article, we critically appraise and debate our reflections as to why exercise and physical activity may not have reached the status of a viable and effective treatment in the clinical care of T2D to the same extent as pharmaceutical drugs. We argue that the reason why exercise therapy is not utilized to a satisfactory degree is multifaceted and primarily relates to a {"}vicious cycle{"} with lack of proven efficacy on T2D complications and a lack of proven effectiveness on risk factors in the primary care of T2D. Furthermore, there is a lack of experimental research establishing the optimal dose of exercise. This precludes widespread and sustained implementation of physical activity and exercise in the clinical treatment of T2D will not succeed.",
keywords = "Diabetes Mellitus, Type 2/therapy, Exercise Therapy, Humans, Hypoglycemic Agents/therapeutic use, Life Style",
author = "Mathias Ried-Larsen and MacDonald, {Christopher S} and Johansen, {Mette Y} and Hansen, {Katrine B} and Robin Christensen and Almdal, {Thomas P} and Pedersen, {Bente K} and Kristian Karstoft",
note = "Copyright {\textcopyright} 2018 John Wiley & Sons, Ltd.",
year = "2018",
month = jul,
doi = "10.1002/dmrr.2999",
language = "English",
volume = "34",
pages = "e2999",
journal = "Diabetes - Metabolism: Research and Reviews",
issn = "1520-7552",
publisher = "John/Wiley & Sons Ltd",
number = "5",

}

RIS

TY - JOUR

T1 - Why prescribe exercise as therapy in type 2 diabetes?

T2 - We have a pill for that!

AU - Ried-Larsen, Mathias

AU - MacDonald, Christopher S

AU - Johansen, Mette Y

AU - Hansen, Katrine B

AU - Christensen, Robin

AU - Almdal, Thomas P

AU - Pedersen, Bente K

AU - Karstoft, Kristian

N1 - Copyright © 2018 John Wiley & Sons, Ltd.

PY - 2018/7

Y1 - 2018/7

N2 - The majority of T2D cases are preventable through a healthy lifestyle, leaving little room for questions that lifestyle should be the first line of defence in the fight against the development of T2D. However, when it comes to the clinical care of T2D, the potential efficacy of lifestyle is much less clear-cut, both in terms of impacting the pathological metabolic biomarkers of the disease, and long-term complications. A healthy diet, high leisure-time physical activity, and exercise are considered to be cornerstones albeit adjunct to drug therapy in the management of T2D. The prescription and effective implementation of structured exercise and other lifestyle interventions in the treatment of T2D have not been routinely used. In this article, we critically appraise and debate our reflections as to why exercise and physical activity may not have reached the status of a viable and effective treatment in the clinical care of T2D to the same extent as pharmaceutical drugs. We argue that the reason why exercise therapy is not utilized to a satisfactory degree is multifaceted and primarily relates to a "vicious cycle" with lack of proven efficacy on T2D complications and a lack of proven effectiveness on risk factors in the primary care of T2D. Furthermore, there is a lack of experimental research establishing the optimal dose of exercise. This precludes widespread and sustained implementation of physical activity and exercise in the clinical treatment of T2D will not succeed.

AB - The majority of T2D cases are preventable through a healthy lifestyle, leaving little room for questions that lifestyle should be the first line of defence in the fight against the development of T2D. However, when it comes to the clinical care of T2D, the potential efficacy of lifestyle is much less clear-cut, both in terms of impacting the pathological metabolic biomarkers of the disease, and long-term complications. A healthy diet, high leisure-time physical activity, and exercise are considered to be cornerstones albeit adjunct to drug therapy in the management of T2D. The prescription and effective implementation of structured exercise and other lifestyle interventions in the treatment of T2D have not been routinely used. In this article, we critically appraise and debate our reflections as to why exercise and physical activity may not have reached the status of a viable and effective treatment in the clinical care of T2D to the same extent as pharmaceutical drugs. We argue that the reason why exercise therapy is not utilized to a satisfactory degree is multifaceted and primarily relates to a "vicious cycle" with lack of proven efficacy on T2D complications and a lack of proven effectiveness on risk factors in the primary care of T2D. Furthermore, there is a lack of experimental research establishing the optimal dose of exercise. This precludes widespread and sustained implementation of physical activity and exercise in the clinical treatment of T2D will not succeed.

KW - Diabetes Mellitus, Type 2/therapy

KW - Exercise Therapy

KW - Humans

KW - Hypoglycemic Agents/therapeutic use

KW - Life Style

U2 - 10.1002/dmrr.2999

DO - 10.1002/dmrr.2999

M3 - Review

C2 - 29488311

VL - 34

SP - e2999

JO - Diabetes - Metabolism: Research and Reviews

JF - Diabetes - Metabolism: Research and Reviews

SN - 1520-7552

IS - 5

ER -

ID: 55741922